S&P 500   4,282.37 (+1.45%)
DOW   33,762.76 (+2.12%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
S&P 500   4,282.37 (+1.45%)
DOW   33,762.76 (+2.12%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
S&P 500   4,282.37 (+1.45%)
DOW   33,762.76 (+2.12%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
S&P 500   4,282.37 (+1.45%)
DOW   33,762.76 (+2.12%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
NASDAQ:MASI

Masimo (MASI) Stock Forecast, Price & News

$163.30
-2.02 (-1.22%)
(As of 06/2/2023 ET)
Compare
Today's Range
$162.54
$166.30
50-Day Range
$155.24
$196.47
52-Week Range
$108.89
$198.00
Volume
365,995 shs
Average Volume
378,713 shs
Market Capitalization
$8.62 billion
P/E Ratio
74.91
Dividend Yield
N/A
Price Target
$188.88

Masimo MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.88 Rating Score
Upside/​Downside
15.7% Upside
$188.88 Price Target
Short Interest
Healthy
2.17% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.86
Upright™ Environmental Score
News Sentiment
0.30mentions of Masimo in the last 14 days
Based on 16 Articles This Week
Insider Trading
Acquiring Shares
$1 M Bought Last Quarter
Proj. Earnings Growth
11.55%
From $4.76 to $5.31 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.58 out of 5 stars

Medical Sector

104th out of 983 stocks

Electromedical Equipment Industry

2nd out of 21 stocks


MASI stock logo

About Masimo (NASDAQ:MASI) Stock

Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. Its products include remote patient monitoring, connectivity, and hospital automation solutions, including Masimo Patient SafetyNet, Masimo Patient SafetyNet Surveillance, Masimo SafetyNet, Masimo SafetyNet-Open, Replica, Iris, MyView, UniView, Uniview: 60, Trace, Masimo Sleep, Centroid, and Bridge. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.

Receive MASI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Masimo and its competitors with MarketBeat's FREE daily newsletter.

MASI Stock News Headlines

"Chilling War Games Show US Forces Crushed" – FOX NEWS
=== BREAKING === "Chilling War Games Show US Forces Crushed" - FOX NEWS After losing to China in repeated war games, U.S. military to spend billions on new "living missile" for armed forces. Investors stand to reap 35,960% on shares of small defense contractor that makes powerful new weapon. Get the name of the stock here >>>
Founder of Masimo Joseph Kiani Buys More Stock
Founder of Masimo Joseph Kiani Buys More Stock \
"Chilling War Games Show US Forces Crushed" – FOX NEWS
=== BREAKING === "Chilling War Games Show US Forces Crushed" - FOX NEWS After losing to China in repeated war games, U.S. military to spend billions on new "living missile" for armed forces. Investors stand to reap 35,960% on shares of small defense contractor that makes powerful new weapon. Get the name of the stock here >>>
StockNews.com Initiates Coverage on Masimo (NASDAQ:MASI)
BTIG Releases a Buy Rating on Masimo (MASI)
Masimo (NASDAQ:MASI) Shares Gap Down to $184.25
See More Headlines

MASI Price History

MASI Company Calendar

Last Earnings
5/09/2023
Today
6/02/2023
Next Earnings (Estimated)
8/08/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:MASI
CUSIP
57479510
Employees
6,000
Year Founded
1989

Price Target and Rating

Average Stock Price Forecast
$188.88
High Stock Price Forecast
$207.00
Low Stock Price Forecast
$150.00
Forecasted Upside/Downside
+15.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.88
Research Coverage
8 Analysts

Profitability

Net Income
$143.50 million
Pretax Margin
6.99%

Debt

Sales & Book Value

Annual Sales
$2.04 billion
Cash Flow
$7.49 per share
Book Value
$25.20 per share

Miscellaneous

Free Float
47,672,000
Market Cap
$8.62 billion
Optionable
Optionable
Beta
0.87

Social Links


Key Executives

  • Joe E. KianiJoe E. Kiani
    Chairman & Chief Executive Officer
  • Bilal MuhsinBilal Muhsin
    Chief Operating Officer
  • Micah YoungMicah Young
    Chief Financial Officer & Executive Vice President
  • Yongsam Lee
    Chief Information Officer & Executive VP
  • Anand SampathAnand Sampath
    Executive VP-Operations & Clinical Research













MASI Stock - Frequently Asked Questions

Should I buy or sell Masimo stock right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Masimo in the last twelve months. There are currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" MASI shares.
View MASI analyst ratings
or view top-rated stocks.

What is Masimo's stock price forecast for 2023?

8 brokers have issued 12-month price objectives for Masimo's stock. Their MASI share price forecasts range from $150.00 to $207.00. On average, they anticipate the company's stock price to reach $188.88 in the next year. This suggests a possible upside of 15.7% from the stock's current price.
View analysts price targets for MASI
or view top-rated stocks among Wall Street analysts.

How have MASI shares performed in 2023?

Masimo's stock was trading at $147.95 at the start of the year. Since then, MASI stock has increased by 10.4% and is now trading at $163.30.
View the best growth stocks for 2023 here
.

Are investors shorting Masimo?

Masimo saw a increase in short interest in May. As of May 15th, there was short interest totaling 1,070,000 shares, an increase of 23.6% from the April 30th total of 865,600 shares. Based on an average daily trading volume, of 369,600 shares, the days-to-cover ratio is currently 2.9 days. Currently, 2.2% of the shares of the stock are sold short.
View Masimo's Short Interest
.

When is Masimo's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023.
View our MASI earnings forecast
.

How were Masimo's earnings last quarter?

Masimo Co. (NASDAQ:MASI) announced its quarterly earnings results on Tuesday, May, 9th. The medical equipment provider reported $0.87 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.83 by $0.04. The medical equipment provider had revenue of $565 million for the quarter, compared to the consensus estimate of $557.87 million. Masimo had a trailing twelve-month return on equity of 19.32% and a net margin of 5.16%. Masimo's revenue was up 85.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.93 earnings per share.

What guidance has Masimo issued on next quarter's earnings?

Masimo updated its FY23 earnings guidance on Tuesday, May, 9th. The company provided earnings per share guidance of $4.70-4.80 for the period, compared to the consensus EPS estimate of $4.76. The company issued revenue guidance of $2.415-2.460 billion, compared to the consensus revenue estimate of $2.44 billion.

What is Joe E. Kiani's approval rating as Masimo's CEO?

136 employees have rated Masimo Chief Executive Officer Joe E. Kiani on Glassdoor.com. Joe E. Kiani has an approval rating of 90% among the company's employees.

What other stocks do shareholders of Masimo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Masimo investors own include NVIDIA (NVDA), Netflix (NFLX), Shopify (SHOP), Okta (OKTA), PayPal (PYPL), Alibaba Group (BABA), Mastercard (MA), Trade Desk (TTD), Walt Disney (DIS) and Twilio (TWLO).

What is Masimo's stock symbol?

Masimo trades on the NASDAQ under the ticker symbol "MASI."

Who are Masimo's major shareholders?

Masimo's stock is owned by a variety of retail and institutional investors. Top institutional investors include FMR LLC (11.57%), BlackRock Inc. (11.30%), State Street Corp (3.24%), Liontrust Investment Partners LLP (1.80%), Geode Capital Management LLC (1.38%) and Farallon Capital Management LLC (1.20%). Insiders that own company stock include Adam Mikkelson, Anand Sampath, Bilal Muhsin, Craig B Reynolds, H Michael Cohen, Joe E Kiani, Jon Coleman, Micah W Young, Tao Levy and Thomas Samuel Mcclenahan.
View institutional ownership trends
.

How do I buy shares of Masimo?

Shares of MASI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Masimo's stock price today?

One share of MASI stock can currently be purchased for approximately $163.30.

How much money does Masimo make?

Masimo (NASDAQ:MASI) has a market capitalization of $8.62 billion and generates $2.04 billion in revenue each year. The medical equipment provider earns $143.50 million in net income (profit) each year or $2.18 on an earnings per share basis.

How many employees does Masimo have?

The company employs 6,000 workers across the globe.

How can I contact Masimo?

Masimo's mailing address is 52 DISCOVERY, IRVINE CA, 92618. The official website for the company is www.masimo.com. The medical equipment provider can be reached via phone at (949) 297-7000, via email at ekammerman@masimo.com, or via fax at 949-297-7001.

This page (NASDAQ:MASI) was last updated on 6/2/2023 by MarketBeat.com Staff

My Account -